GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TheraCryf PLC (FRA:8EV) » Definitions » Dividends Received

TheraCryf (FRA:8EV) Dividends Received


View and export this data going back to 2018. Start your Free Trial

What is TheraCryf Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.


TheraCryf Business Description

Traded in Other Exchanges
Address
Congleton Road, Alderley Park, Nether Alderley, Cheshire, GBR, SK10 4TG
TheraCryf PLC is a clinical-stage biotechnology company focused on profitable segments in oncology and neuropsychiatry. The company's lead clinical asset, SFX-01 is a patented form of delivering sulforaphane, which could be used in the treatment of a number of cancers, neurodevelopmental disorders, and other diseases.